FIND

How do you get tested for TB? If you or your doctor think that you may have TB, the first step is usually a chest X-ray. What happens if you have an X-ray but no radiologist to read it? FIND is supporting the development of Computer-Assisted Detection tools that can read images as a means of filling the diagnostic gap.

Are you a healthcare professional in Nairobi? Are you passionate about diabetes care? You are invited to an in-person CGM training workshop co-hosted by ACCEDE and KDSF Attendance is free, but space is limited, so you must register in advance. https://lnkd.in/ezGX8Xs8

We are happy to share that results from a pharmacy channel market activation pilot conducted with our partner SwipeRx were recently published in PLOS ONE. The study demonstrates the potential of the pharmacy channel in making COVID-19 self-tests more accessible in Vietnam. Pharmacy professionals trained through the pilot showed significantly greater confidence in stocking, dispensing, and counseling clients on self-use Ag-RDTs. By the end of the nine-month engagement, 92% of trained professionals stocked at least one quality-assured self-test, compared to just 29% of untrained professionals. These findings highlight the power of the pharmacy channel in expanding access to critical diagnostics. Karishma Mutreja and Anabel Gomez https://lnkd.in/dHxhM6Sp

When is a cough not just a cough? A persistent cough lasting more than 2 weeks could be a symptom of something more serious – including TB. It is essential to get tested. TB IS preventable, and it IS curable.

How do we stop the spread of TB? We need simple, rapid and affordable tests that work for everyone, everywhere. Since 2010, FIND has worked with 17 countries to optimize their diagnostic networks. Ensuring you have the right kind of tests available in the right place leads to quicker results, fewer resources used, and better outcomes for the patients.

Did you know? 1 in 4 people worldwide carries the TB bacillus. Of those who carry the disease, only 5-10% will fall ill. Some risk factors for developing TB include: weakened immune systems, living with diabetes, living with HIV, and being malnourished, among others. Protect those around you – get tested and treated for TB.

Our request for proposal for a manufacturing and commercialization partner for an antigen-based rapid diagnostic test for Neisseria gonorrhoeae infection with a focus in low- and middle-income countries is still open! Link to have more details and to apply in the comments ⤵️

🚨New request for proposal: consultant for risk and compliance management 🚨 We are seeking the consultancy services of a risk and compliance specialist who will support putting in place robust systems to ensure compliance to the regulatory and institutional policies, and procedures that regulate our work. Submit your application before 1 April 2025! More details here: https://lnkd.in/e3XmWkRH

In case you have registered to the Women in Malaria online conference, don't forget to join the round table tomorrow on "What if women were leading the fight against malaria?". Our Scientist, Elena Marbán Castro, will join the discussion alongside esteemed speakers from 12:35 to 13:50 UTC. Full programme here: https://lnkd.in/dv4Nyim6

📢 Neonatal sepsis landscape survey: your input is needed! We are excited to announce our collaboration with NEST360 on a key initiative to improve neonatal sepsis diagnostics. As part of this effort, we are conducting a survey to gather valuable information and create a neonatal sepsis diagnostic landscape. We invite your company to participate and be featured in an online compendium showcasing innovative diagnostic solutions for neonatal sepsis. By participating, your company will: ✅ Gain global recognition in the health community ✅ Increase visibility and foster potential collaborations ✅ Highlight your product to customers actively seeking cutting-edge diagnostic tools Who should participate? - Companies with commercialized or in-development neonatal sepsis diagnostic solutions - Companies with adult sepsis diagnostics looking to expand into the neonatal space Note: tests based on single biomarkers (CRP, PCT) and blood culture are out of scope. Complete the survey by 31 March 2025 to contribute to this important global initiative to improve neonatal care worldwide! ⤵️ 🔗 https://lnkd.in/ep3ugyYA ❓ Have questions or need more details? Reach out to us at testdirectory@finddx.org! #NeonatalSepsis #Diagnostics #GlobalHealth #SepsisDiagnostics #NeonatalCare #InnovativeDiagnostics #GlobalHealthInnovation #NeonatalInnovation